These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 28650861)
1. Microbiome in interstitial lung disease: from pathogenesis to treatment target. Salisbury ML; Han MK; Dickson RP; Molyneaux PL Curr Opin Pulm Med; 2017 Sep; 23(5):404-410. PubMed ID: 28650861 [TBL] [Abstract][Full Text] [Related]
2. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies. Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183 [TBL] [Abstract][Full Text] [Related]
3. Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases. Amati F; Stainer A; Mantero M; Gramegna A; Simonetta E; Suigo G; Voza A; Nambiar AM; Cariboni U; Oldham J; Molyneaux PL; Spagnolo P; Blasi F; Aliberti S Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055163 [TBL] [Abstract][Full Text] [Related]
4. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis. Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761 [TBL] [Abstract][Full Text] [Related]
5. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. Spagnolo P; Molyneaux PL; Bernardinello N; Cocconcelli E; Biondini D; Fracasso F; Tiné M; Saetta M; Maher TM; Balestro E Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717661 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Varone F; Gibiino G; Gasbarrini A; Richeldi L Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146 [TBL] [Abstract][Full Text] [Related]
8. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660 [TBL] [Abstract][Full Text] [Related]
10. The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease. O'Dwyer DN; Dickson RP; Moore BB J Immunol; 2016 Jun; 196(12):4839-47. PubMed ID: 27260767 [TBL] [Abstract][Full Text] [Related]
11. Role of the Microbiome in Interstitial Lung Diseases. Chioma OS; Hesse LE; Chapman A; Drake WP Front Med (Lausanne); 2021; 8():595522. PubMed ID: 33604346 [TBL] [Abstract][Full Text] [Related]
12. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis. Invernizzi R; Molyneaux PL Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290 [TBL] [Abstract][Full Text] [Related]
13. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Wang L; Hao K; Yang T; Wang C Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603 [TBL] [Abstract][Full Text] [Related]
14. The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity. Dickson RP; Erb-Downward JR; Falkowski NR; Hunter EM; Ashley SL; Huffnagle GB Am J Respir Crit Care Med; 2018 Aug; 198(4):497-508. PubMed ID: 29533677 [TBL] [Abstract][Full Text] [Related]
15. Role of the lung microbiome in HIV pathogenesis. Shenoy MK; Lynch SV Curr Opin HIV AIDS; 2018 Jan; 13(1):45-52. PubMed ID: 29035946 [TBL] [Abstract][Full Text] [Related]
17. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival. Hyldgaard C Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544 [TBL] [Abstract][Full Text] [Related]
18. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis. Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277 [TBL] [Abstract][Full Text] [Related]
19. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease. Cribbs SK; Beck JM Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681 [TBL] [Abstract][Full Text] [Related]
20. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I; Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]